Survival with cetuximab/FOLFOX or cetuximab/FOLFIRI of patients with nonresectable colorectal liver metastases in the CELIM study.

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Contributors

  • Gunnar Folprecht - , Department of Internal Medicine I (Author)
  • Thomas Gruenberger - (Author)
  • Wolf Bechstein - (Author)
  • Florian Lordick - (Author)
  • Hauke Lang - (Author)
  • Jurgen Weitz - (Author)
  • Thomas Suedhoff - (Author)
  • Joerg Thomas Hartmann - (Author)
  • Torsten Liersch - (Author)
  • Claus-Henning Kohne - (Author)

Details

Original languageGerman
Number of pages2
JournalJournal of clinical oncology
Volume30
Issue number4
Publication statusPublished - 1 Feb 2012
Peer-reviewedYes

External IDs

ORCID /0000-0002-9321-9911/work/142252014

Keywords